Ruth E. Brown

Integration in Interscholastic Sport: What is still missing 23 years after ADA?

Ruth E. Brown, Ruth E. Brown, 2013 .

An example of using computer simulation to predict pharmaceutical costs and outcomes

Dennis A. Revicki, Michael T. Halpern, Ruth E. Brown, 1994, Proceedings of Winter Simulation Conference.

The Use of Technology Assessment by Hospitals, Health Maintenance Organizations, and Third-Party Payers in the United States

Ruth E. Brown, B. Luce, R. Brown, 1995, International Journal of Technology Assessment in Health Care.

Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome.

Ruth E. Brown, S. Hassenbusch, G. de Lissovoy, 1997, Clinical therapeutics.

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.

Ruth E. Brown, H. Margolis, R. Brown, 1995, JAMA.

Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.

Ruth E. Brown, D. Feeny, D. Revicki, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cost-effectiveness of newer antidepressants compared with tricyclic antidepressants in managed care settings.

Ruth E. Brown, M. Keller, D. Revicki, 1997, The Journal of clinical psychiatry.

Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients.

Ruth E. Brown, D. Revicki, B. Luce, 1990, Hospital & community psychiatry.

Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy.

J Hutton, M L Simoons, Ruth E. Brown, 2002, European heart journal.

Health-care expenditures for tuberculosis in the United States.

R. M. Nicola, Ruth E. Brown, W. R. Taylor, 1995, Archives of internal medicine.